Allentown, NJ, United States of America

Donna M Huym

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donna M. Huym: Innovator in Thromboxane A2 Receptor Antagonists

Introduction

Donna M. Huym is a prominent inventor based in Allentown, NJ (US). She has made significant contributions to the field of pharmacology, particularly in the development of thromboxane A2 (TP) receptor antagonists. Her work focuses on innovative compounds that have the potential to cross the blood-brain barrier, offering new avenues for treatment.

Latest Patents

Donna M. Huym holds 1 patent related to her research on thromboxane A2 receptor antagonists. The patent details novel TP receptor antagonists that can be utilized in methods for treating disorders associated with the activation of the TP receptor. This invention represents a significant advancement in therapeutic options for various medical conditions.

Career Highlights

Donna is affiliated with the University of Pennsylvania, where she conducts her research and development work. Her academic background and ongoing research contribute to the advancement of medical science, particularly in understanding and treating disorders linked to thromboxane A2 receptors.

Collaborations

Throughout her career, Donna has collaborated with esteemed colleagues, including John Q. Trojanowski and Virginia Man-Yee Lee. These partnerships enhance the scope and impact of her research, fostering a collaborative environment that drives innovation.

Conclusion

Donna M. Huym is a dedicated inventor whose work on thromboxane A2 receptor antagonists holds promise for future medical treatments. Her contributions to the field exemplify the importance of innovation in addressing complex health issues.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…